A surprising, paradoxical relationship between a tumor
suppressor molecule and an oncogene may be the key to explaining and working around how breast cancer tumor cells become desensitized to a common cancer drug, found researchers at the Perelman School of Medicine at the University of Pennsylvania.
New research shows that microRNA - 486 is a potent tumor -
suppressor molecule in lung cancer, and that the it helps regulate the proliferation and migration of lung - cancer cells, and the induction of programmed cell death, or apoptosis, in those cells.
A UNC Lineberger Comprehensive Cancer Center discovery of just how a certain tumor
suppressor molecule works to prevent tumor growth could lead to a personalized treatment approach for colon cancer.
Not exact matches
According to Eckmann, «The special thing about these processes is that they involve known
molecules with very long evolutionary histories, previously receiving attention as
suppressors of tumour formation within the context of normal cell division.
But mutated or dysfunctional Rb is associated with several major cancers and Cyclin D has long been described as an oncogene that promotes cancer because it was believed to inactivate the Rb tumor
suppressor function through a process called phosphorylation, which involves phosphate
molecules being added to proteins, essentially turning them on or off.
«MicroRNA
molecule found to be potent tumor -
suppressor in lung cancer.»
The drug, lapatinib, activates the
suppressor called FOXO, in HER2 + breast cancer cells, but then FOXO becomes a turncoat
molecule, working with an epigenetic regulator that controls gene expression.
These
molecules have caused controversy due to the possible side effects of blocking Cdh1, which is considered a tumour
suppressor.
Through genetic engineering techniques, it is now possible to introduce
suppressor (Su +) tRNA
molecules into mammalian cells.
Rather than a tumour
suppressor, we show here that RASAL2 actually acts as a cancer promoting
molecule in TNBC.
Recent active research in miRNA identified a series of this type of
molecules that are involved in tumor progression in various tumors as oncogenes and tumor
suppressors (8, 9).
Within this cascade Shp2 turns on different signaling
molecules, but turns off the tumor
suppressor genes p27 und p53.